Structure of a single model to describe plutonium and americium decorporation by DTPA treatments

Health Physics

Volumn 99, Issue 4, 2010, Pages 553-559

  Fritsch, P ^a   Serandour A L ^a   Gremy O ^a   Phan, G ^b   Tsapis, N ^c   Fattal, E ^c   Benech, H ^b   Deverre, J R ^d   Poncy, J L ^a  

^a CEA DIF   (France)

^b Institut National de la Recherche Agronomique   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d DIF   (France)

Author keywords

241Am; biokinetics; modeling, biological; pharmacokinetics

Indexed keywords

AMERICIUM; PENTETIC ACID; PLUTONIUM; RADIOPROTECTIVE AGENT;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; BIOLOGICAL MODEL; CHEMISTRY; DRUG EFFECT; EXPOSURE; FECES; INTRAVENOUS DRUG ADMINISTRATION; MALE; RAT; SPRAGUE DAWLEY RAT; TIME; TISSUE DISTRIBUTION; URINE; WASTE MANAGEMENT;

AMERICIUM; ANIMALS; AUTORADIOGRAPHY; DECONTAMINATION; FECES; INHALATION EXPOSURE; INJECTIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; PENTETIC ACID; PLUTONIUM; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 77957344851     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/HP.0b013e3181c1cccd     Document Type: Article

References (23)

1. André S, Charuau J, Rateau G, Vavasseur C, Métivier H. Design of a new inhalation device for rodents and primates. J Aerosol Sci 6:647- 656; 1989.
2. Ansoborlo E, Prat O, Moisy P, Den Auver C, Guilbaud P, Carriere M, Gouget B, Duffield J, Doizi D, Vercouter T, Moulin C, Moulin V. Actinide speciation in relation with biological processes. Biochimie 88:1605-1618; 2006.
3. Bhattacharyya MH, Peterson DP. Action of DTPA on hepatic plutonium. III. Evidence for a direct chelation mechanism for DTPA-induced excretion of monomeric plutonium into rat bile. Radiat Res 80:108 -115; 1979.
4. Breustedt B, Blanchardon E, Fritsch P, Giussani A, Lopez MA, Luciani A, Piechowski J, Schimmelfeng J, Sérandour AL. Biokinetic modelling of DTPA decorporation therapy: the Conrad approach. Radiat Protect Dosim 134:38-48; 2009.
5. Durbin PW, Kullgren B, Schmidt CT. Circulatory kinetics of intravenously injected 238Pu(IV) citrate and 14C-CaNa3- DTPA in mice: comparison with rat, dog, and reference man. Health Phys 72:222-235; 1997.
6. Fritsch P, Grappin L, Guillermin AM, Fottorino R, Ruffin M, Mièle A. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches. Radiat Protect Dosim 127:120 -124; 2007.
7. Fritsch P, Sérandour AL, Grémy O, Phan G, Tsapis N, Abram MC, Renault D, Fattal E, Benech H, Deverre JR, Poncy JL. Simplified structure of a new model to describe urinary excretion of Pu after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments. Radiat Res 171:674-686; 2009.
8. Gervelas C, Sérandour AL, Geiger S, Grillon G, Fritsch P, Taulelle C, Le Gall B, Benech H, Deverre JR, Fattal E, Tsapis N. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium. J Control Release 118:78-86; 2007.
9. Hall RM, Poda GA, Fleming RR, Smith JA. A mathematical model for estimation of plutonium in the human body from urine data influenced by DTPA therapy. Health Phys 34:419-432; 1978.
10. Hirano S, Kodama N, Shibata K, Suzuki KT. Distribution, localisation, and pulmonary effects of yttrium chloride following intratracheal instillation into the rat. Toxicol Appl Pharmacol 104:301-311; 1990. (Pubitemid 20214823)
11. International Union of Pure and Applied Chemistry. Stability constants database. Timble, UK: Academic Software; 2004.
12. James AC, Sasser LB, Stuit DB, Glover SE, Carbaugh EH. USTUR whole body case 0269: demonstrating effectiveness of I.V. Ca-DTPA for Pu. Radiat Protect Dosim 127:114- 119; 2007.
13. Ménétrier F, Grappin L, Raynaud P, Courtay C, Wood R, Joussineau S, List V, Stradling GN, Taylor DM, Bérard P, Morcillo MA, Rencova J. Treatment of accidental intakes of plutonium and americium: guidance notes. Appl Radiat Isot 62:829-846; 2005.
14. Phan G, Herbet A, Cholet S, Benech H, Deverre JR, Fattal E. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation. J Control Release 110:177-188; 2005.
15. Ramounet B, Matton S, Guezingar-Liebard F, Abram MC, Rateau G, Grillon G, Fritsch P. Comparative biokinetics of plutonium and americium after inhalation of PuO2 and mixed oxides (U, Pu)O2 in rat. Int J Radiat Biol 76:215- 222; 2000.
16. Roedler HD, Nobke D, Ohlenschläger L, Schieferdecker H, Doerfel H, Renz K. Incorporation of 241Am: effectiveness of late DTPA chelation therapy. Radiat Protect Dosim 26:377- 379; 1989.
17. Sérandour AL, Fritsch P. Pulmonary retention of actinides after dissolution of PuO2 aerosols: interest in modelling DTPA decorporation. Radioprotection 43:239 -254; 2008.
18. Sérandour AL, Grémy O, Fréchou M, Renault D, Poncy JL, Fritsch P. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retentiontissues after a systemic contamination followed by an early DTPA treatment. Radiat Res 170:208 -215; 2008.
19. Stather JW, Smith H, Bailey MR, Birchall A, Bulman RA, Crawley FEH. The retention of 14C-DTPA in human volunteers after inhalation or intravenous injection. Health Phys 44:45-52; 1983.
20. Stather JW, Stradling GN, Gray SA, Moody J, Hodgson A. Use of DTPA for increasing the rate of elimination of plutonium-238 and americium-241 from rodents after their inhalation as the nitrates. Hum Toxicol 4:573-582; 1985.
21. Stradling GN, Stather JW, Sumner SA, Strong JC, Lennox AM, Ham SE. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA. Health Phys 46:919 -924; 1984.
22. Taylor DM, Hodgson SA, Stradling N. Treatment of human contaminations with plutonium and americium: Would orally administered Ca- or Zn-DTPA be effective? Radiat Protect Dosim 127:469-471; 2007.
23. Turner GA, Taylor DM. The transport of plutonium, americium and curium in the blood of rats. Phys Med Biol 13:535-546; 1968.